Group 1 - The core point of the article highlights the performance and holdings of the ICBC Frontier Medical Stock A fund, which has a recent net value of 3.3960 yuan, reflecting a decline of 2.19% [1] - The fund has shown a one-month return of 10.22%, a six-month return of 29.67%, and a year-to-date return of 29.08%, with respective rankings of 252 out of 1022, 86 out of 985, and 130 out of 975 in its category [1] - The top ten holdings of the fund account for a total of 59.44%, with significant positions in companies such as Heng Rui Pharmaceutical (9.51%), Kelun Pharmaceutical (9.16%), and Xinlitai (6.70%) [1] Group 2 - The ICBC Frontier Medical Stock A fund was established on February 3, 2016, and as of June 30, 2025, it has a total scale of 9.33 billion yuan, managed by fund manager Zhao Bei [1] - Zhao Bei holds a master's degree and has extensive experience in the investment management field, having served in various roles since joining ICBC Credit Suisse in 2010 [2]
8月7日工银前沿医疗股票A净值下跌2.19%，近1个月累计上涨10.22%
Sou Hu Cai Jing·2025-08-07 14:05